Cardior Pharmaceuticals raised €64M in a Series B round in Aug 2021. The company is based in Hanover, Germany. Investors in the round: BioMedPartners, Bristol Myers Squibb, Coparion and 6 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €64M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
